- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
Description GS-441524, predominant metabolite of Remdesivir and superior to Remdesivir against Covid-19 , shows comparable efficacy in cell-based models of primary human lung and cat cells infected with coronavirus. GS-441524 could strongly inhibits feline infectious peritonitis virus (FIPV), with an EC50 of 0.78 μM[1][2][3].
IC50 & Target EC50: 0.78 μM (FIPV)[1].
In Vitro The cells appear and grow normally at all concentrations of GS-441524 and fail to uptake the fluorescent dye CellTox Green at 24 h. The cytotoxic concentration-50% (CC50) is therefore>100 μM. The effective concentration-50% (EC50) of GS-441524 is calculated to be 0.78 μM[1].
In Vivo All 10 treated cats have a rapid response to treatment and lymphocyte levels and rectal temperatures return to pre-infection levels and levels of the two asymptomatic cats. All ten of the once or twice treated cats have remained normal to date (more than eight months post infection). Injections cause a transient "stinging" reaction in some cats within 10 s of compound administration. Localized and transient pain is evidenced by unusual posturing, licking at the injection site and/or vocalizations that last for approximately 30-60 s after injection. Injection reactions are more pronounced in some animals relative to others and reactions are inconsistent from one injection to the next and decreas over time[1].
Remdesivi (IV injection) in NHP results in GS-441524 being present in serum at concentrations 1000-fold higher than Remdesivir throughout a 7-day treatment course[3].Molecular Weight 291.26
Formula C₁₂H₁₃N₅O₄
CAS No. 1191237-69-0
SMILES N#C[C@@]1(C2=CC=C3N2N=CN=C3N)O[C@H](CO)[C@@H](O)[C@H]1O
Shipping Room temperature in continental US; may vary elsewhere.
Storage 4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
Solvent & Solubility In Vitro:
DMSO : 125 mg/mL (429.17 mM; Need ultrasonic)
Preparing
Stock SolutionsConcentrationSolventMass 1 mg 5 mg 10 mg
*1 mM 3.4334 mL 17.1668 mL 34.3336 mL 5 mM 0.6867 mL 3.4334 mL 6.8667 mL 10 mM 0.3433 mL 1.7167 mL 3.4334 mL 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。 -80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶-
1.
请依序添加每种溶剂: 10% DMSO 40% PEG300 5% Tween-80 45% saline
Solubility: ≥ 2.08 mg/mL (7.14 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (7.14 mM,饱和度未知) 的澄清溶液。
以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。
-
2.
请依序添加每种溶剂: 10% DMSO 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.08 mg/mL (7.14 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (7.14 mM,饱和度未知) 的澄清溶液。
以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。
-
3.
请依序添加每种溶剂: 10% DMSO 90% corn oil
Solubility: ≥ 2.08 mg/mL (7.14 mM); Clear solution
此方案可获得 ≥ 2.08 mg/mL (7.14 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。
以 1 mL 工作液为例,取 100 μL 20.8 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。
-
4.
请依序添加每种溶剂: 5% ethanol, 30% propylene glycol, 45% PEG 400, 20% water (pH 1.5 with HCI)
Solubility: 10 mg/mL (34.33 mM); Clear solution; Need ultrasonic and adjust pH to 2 with HCl
*以上所有助溶剂都可在 IVDSHOW 网站选购。
References 关键词:- IVDSHOW GS-441524
-
-
产品组分
组分内容
型号
规格 价格 储存温度
IVDSHOW GS-441524
I-1000-01 1g|瓶